Off-label use of 0.19 mg fluocinolone acetonide intravitreal implant: A Systematic Review
Corticosteroids are used in a variety of ophthalmological diseases. One challenge faced by ophthalmologists is to deliver corticosteroids to the posterior segment of the eye with efficacy and safety. Sustained-release corticosteroid implants may be the answer to this problem. The 0.19 mg fluocinolon...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2021
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/10216/134569 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/134569 |